FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1795-1797 November 28, 2002 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The renin–angiotensin system is a master regulator of human physiology. It controls blood pressure and fluid and electrolyte balance through coordinated effects on the heart, blood vessels, and kidneys. In the classic pathway of the renin–angiotensin system, renin is secreted from the juxtaglomerular apparatus of the kidney and acts on the circulating precursor angiotensinogen to generate angiotensin I (Figure 1). Angiotensin I has little effect on blood pressure and is converted in the lungs by angiotensin-converting enzyme (ACE) to angiotensin II. A potent vasopressor, angiotensin II acts on the heart and the kidneys by binding to the G . . . [Full Text of this Article]

This article has been cited by other articles:

• Zhong, J.-C., Yu, X.-Y., Huang, Y., Yung, L.-M., Lau, C.-W., Lin, S.-G. (2007). Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 74: 388-395 [Abstract] [Full Text]  
• Wakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., Makino, Y., Kato, N., Koni, I., Miyamori, I. (2007). Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 Ratio. Endocrinology 148: 2453-2457 [Abstract] [Full Text]  
• Zulli, A., Burrell, L. M., Widdop, R. E., Black, M. J., Buxton, B. F., Hare, D. L. (2006). Immunolocalization of ACE2 and AT2 Receptors in Rabbit Atherosclerotic Plaques. J. Histochem. Cytochem. 54: 147-150 [Abstract] [Full Text]  
• Kittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G., Garcia, J. G. N., Hare, J. M. (2005). Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics 21: 299-307 [Abstract] [Full Text]  
• Zhong, J.-C., Huang, D.-Y., Yang, Y.-M., Li, Y.-F., Liu, G.-F., Song, X.-H., Du, K. (2004). Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats. Hypertension 44: 907-912 [Abstract] [Full Text]  
• McFarlane, S. I., Winer, N., Sowers, J. R. (2003). Role of the Natriuretic Peptide System in Cardiorenal Protection. Arch Intern Med 163: 2696-2704 [Abstract] [Full Text]  
• Yagil, Y., Yagil, C. (2003). Hypothesis: ACE2 Modulates Blood Pressure in the Mammalian Organism. Hypertension 41: 871-873 [Full Text]  
• Ferrario, C. M. (2003). Commentary on Tikellis et al: There Is More to Discover About Angiotensin-Converting Enzyme. Hypertension 41: 390-391 [Full Text]